Clinical outcomes of COVID-19 in Wuhan, China: a large cohort study
Jiao Liu(Shanghai Jiao Tong University), Dechang Chen(Shanghai Jiao Tong University), Xiaofei Ye(Second Military Medical University), Lidi Zhang(Shanghai Jiao Tong University), Xuan Dong(The Ohio State University), Jieming Qu(Shanghai Jiao Tong University), Hangxiang Du(Shanghai Jiao Tong University), Zhixiong Wu(Fudan University), Guang Li(Capital Medical University), Tao Wang(Shanghai Jiao Tong University), Limin Chen(Shanghai Jiao Tong University), You Shang(Huazhong University of Science and Technology), Sheng Zhang(Shanghai Jiao Tong University), Yizhu Chen(Shanghai Jiao Tong University), SiSi Huang(Shanghai Jiao Tong University), Yongan Liu(Shanghai Jiao Tong University), Zhenliang Wen(Shanghai Jiao Tong University)
Cited by 146
Related Papers
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies
|Frontiers in Cellular Neuroscience|2017|452
Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
|Nature Communications|2020|432
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19
|Immunity|2020|387
Plasma metabolomic and lipidomic alterations associated with COVID-19
|National Science Review|2020|367